15. EARNINGS PER SHARE

3 Months Ended

Dec. 31, 2020

Net (loss) income per share:

EARNINGS PER SHARE

The following table sets forth the computation of basic and diluted earnings per share for the following periods:

	Three Months Ended
	December 31, 2020			December 31,  2019
Basic:
Net income (loss) continuing operations	$	(9,395,621	)	$	12,970,965
Preferred dividends paid		100,050			66,734
Net income (loss) continuing operations adjusted for preferred dividend		(9,495,671	)		12,904,231
Net income (loss) discontinued operations		-			(41,202	)
Net income (loss) attributable to cbdMD, Inc. common shareholders		(9,495,671	)		12,929,763
Diluted:
Net income (loss) continuing operations		(9,395,621	)		12,970,965
Net income (loss) discontinued operations		-			(41,202	)
Net income(loss)		(9,395,621	)		12,929,763
Shares used in computing basic earnings per share		52,130,870			27,720,356
Effect of dilutive securities:
Options		-			-
Warrants		-			-
Convertible preferred shares		-			833,500
Shares used in computing diluted earnings per share		52,130,870			28,553,856
Earnings per share Basic:
Continued operations		(0.18	)		0.46
Discontinued operations		(0.00	)		(0.00	)
Basic earnings per share		(0.18	)		0.46
Earnings per share Diluted:
Continued operations		(0.18	)		0.45
Discontinued operations		-			-
Diluted earnings per share		(0.18	)		0.45

At the three months ended December 31, 2020, 3,214,686 potential shares underlying options, unvested RSUs and warrants as well as 4,667,600 shares of our 8.0% Series A Cumulative Convertible Preferred Stock were excluded from the shares used to calculate diluted loss per share as their inclusion would reduce net loss per share.